Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$44.94
2.054.78%
At close: -
$44.94
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Twist Bioscience Analyst Ratings and Price Targets | NASDAQ:TWST | Benzinga
Twist Bioscience Corp has a consensus price target of $47.36 based on the ratings of 14 analysts. The high is $62 issued by Scotiabank on February 4, 2025. The low is $27 issued by Berenberg on September 27, 2023. The 3 most-recent analyst ratings were released by Scotiabank, JP Morgan, and Baird on February 4, 2025, respectively. With an average price target of $52 between Scotiabank, JP Morgan, and Baird, there's an implied 15.71% upside for Twist Bioscience Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Scotiabank
JP Morgan
Baird
Wolfe Research
TD Cowen
1calculated from analyst ratings
Analyst Ratings for Twist Bioscience
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/04/2025 | Buy Now | 37.96% | Scotiabank | Sung Ji Nam46% | $54 → $62 | Maintains | Sector Outperform | Get Alert |
| 02/04/2025 | Buy Now | -10.99% | JP Morgan | Rachel Vatnsdal59% | $35 → $40 | Maintains | Underweight | Get Alert |
| 02/04/2025 | Buy Now | 20.16% | Baird | Catherine Ramsey58% | $48 → $54 | Maintains | Outperform | Get Alert |
| 12/13/2024 | Buy Now | 33.51% | Wolfe Research | Doug Schenkel71% | → $60 | Initiates | → Outperform | Get Alert |
| 11/26/2024 | Buy Now | 29.06% | TD Cowen | Steven Mah51% | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 11/19/2024 | Buy Now | 15.71% | Barclays | Luke Sergott50% | $55 → $52 | Maintains | Overweight | Get Alert |
| 11/19/2024 | Buy Now | 20.16% | Scotiabank | Sung Ji Nam46% | $50 → $54 | Maintains | Sector Outperform | Get Alert |
| 11/19/2024 | Buy Now | 6.81% | Baird | Catherine Ramsey58% | $46 → $48 | Maintains | Outperform | Get Alert |
| 10/17/2024 | Buy Now | 6.81% | Leerink Partners | — | $45 → $48 | Maintains | Market Perform | Get Alert |
| 10/01/2024 | Buy Now | 24.61% | Evercore ISI Group | Vijay Kumar53% | $52 → $56 | Maintains | Outperform | Get Alert |
| 08/05/2024 | Buy Now | 22.39% | Barclays | Luke Sergott50% | $60 → $55 | Maintains | Overweight | Get Alert |
| 08/05/2024 | Buy Now | -22.12% | JP Morgan | Tycho Peterson83% | $28 → $35 | Maintains | Underweight | Get Alert |
| 08/05/2024 | Buy Now | 2.36% | Baird | Catherine Ramsey58% | $40 → $46 | Maintains | Outperform | Get Alert |
| 07/09/2024 | Buy Now | 22.39% | Goldman Sachs | Matthew Sykes66% | $45 → $55 | Maintains | Buy | Get Alert |
| 06/28/2024 | Buy Now | 33.51% | Barclays | Luke Sergott50% | $45 → $60 | Maintains | Overweight | Get Alert |
| 06/13/2024 | Buy Now | 44.64% | TD Cowen | Steven Mah51% | $55 → $65 | Maintains | Buy | Get Alert |
| 06/05/2024 | Buy Now | 17.94% | Guggenheim | Subbu Nambi37% | → $53 | Initiates | → Buy | Get Alert |
| 05/06/2024 | Buy Now | 6.81% | Scotiabank | Sung Ji Nam46% | $43 → $48 | Maintains | Sector Outperform | Get Alert |
| 05/03/2024 | Buy Now | 11.26% | Evercore ISI Group | Vijay Kumar53% | $46 → $50 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | 0.13% | Barclays | Luke Sergott50% | $40 → $45 | Maintains | Overweight | Get Alert |
| 05/03/2024 | Buy Now | -10.99% | Baird | Catherine Ramsey58% | $39 → $40 | Maintains | Outperform | Get Alert |
| 04/10/2024 | Buy Now | -10.99% | Barclays | Luke Sergott50% | $45 → $40 | Maintains | Overweight | Get Alert |
| 02/05/2024 | Buy Now | -4.32% | Scotiabank | Sung Ji Nam46% | $30 → $43 | Maintains | Sector Outperform | Get Alert |
| 01/25/2024 | Buy Now | 0.13% | Barclays | Luke Sergott50% | $30 → $45 | Maintains | Overweight | Get Alert |
| 01/18/2024 | Buy Now | 0.13% | Goldman Sachs | Matthew Sykes66% | $25 → $45 | Maintains | Buy | Get Alert |
| 01/17/2024 | Buy Now | 0.13% | Goldman Sachs | Matthew Sykes66% | $25 → $45 | Upgrade | Neutral → Buy | Get Alert |
| 09/27/2023 | Buy Now | -39.92% | Berenberg | Gaurav Goparaju23% | → $27 | Initiates | → Buy | Get Alert |
| 08/07/2023 | Buy Now | -42.15% | Barclays | Luke Sergott50% | $20 → $26 | Maintains | Overweight | Get Alert |
| 07/13/2023 | Buy Now | -55.5% | Goldman Sachs | Matthew Sykes66% | $18 → $20 | Maintains | Neutral | Get Alert |
| 05/08/2023 | Buy Now | -59.95% | Baird | Catherine Ramsey58% | $29 → $18 | Maintains | Outperform | Get Alert |
| 05/08/2023 | Buy Now | -55.5% | Barclays | Luke Sergott50% | $32 → $20 | Maintains | Overweight | Get Alert |
| 04/19/2023 | Buy Now | -55.5% | Goldman Sachs | Matthew Sykes66% | $43 → $20 | Maintains | Neutral | Get Alert |
| 04/18/2023 | Buy Now | -55.5% | Goldman Sachs | Matthew Sykes66% | $43 → $20 | Maintains | Neutral | Get Alert |
| 02/06/2023 | Buy Now | -4.32% | Goldman Sachs | Matthew Sykes66% | $50 → $43 | Maintains | Neutral | Get Alert |
| 02/06/2023 | Buy Now | -35.47% | Baird | Catherine Ramsey58% | $33 → $29 | Maintains | Outperform | Get Alert |
| 02/06/2023 | Buy Now | -28.79% | Barclays | Luke Sergott50% | $37 → $32 | Maintains | Overweight | Get Alert |
| 01/30/2023 | Buy Now | -17.67% | Barclays | Luke Sergott50% | $43 → $37 | Maintains | Overweight | Get Alert |
| 01/05/2023 | Buy Now | -26.57% | Scotiabank | Sung Ji Nam46% | → $33 | Initiates | → Sector Outperform | Get Alert |
| 01/03/2023 | Buy Now | -19.89% | Evercore ISI Group | Vijay Kumar53% | $28 → $36 | Upgrade | In-Line → Outperform | Get Alert |
| 11/21/2022 | Buy Now | -26.57% | Baird | Catherine Schulte68% | $56 → $33 | Maintains | Outperform | Get Alert |
| 11/21/2022 | Buy Now | -4.32% | Barclays | Luke Sergott50% | $45 → $43 | Maintains | Overweight | Get Alert |
| 11/21/2022 | Buy Now | -33.24% | SVB Leerink | Puneet Souda56% | $45 → $30 | Maintains | Market Perform | Get Alert |
| 10/07/2022 | Buy Now | 0.13% | SVB Leerink | Puneet Souda56% | $50 → $45 | Maintains | Market Perform | Get Alert |
| 10/06/2022 | Buy Now | 0.13% | Barclays | Luke Sergott50% | $55 → $45 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | 22.39% | Barclays | Luke Sergott50% | $45 → $55 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | 11.26% | SVB Leerink | Puneet Souda56% | $45 → $50 | Maintains | Market Perform | Get Alert |
| 07/13/2022 | Buy Now | 0.13% | Barclays | Luke Sergott50% | $40 → $45 | Maintains | Overweight | Get Alert |
| 05/09/2022 | Buy Now | -10.99% | Barclays | Luke Sergott50% | $60 → $40 | Maintains | Overweight | Get Alert |
| 04/13/2022 | Buy Now | 22.39% | Goldman Sachs | Matthew Sykes66% | $105 → $55 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Twist Bioscience (TWST) stock?
The latest price target for Twist Bioscience (NASDAQ:TWST) was reported by Scotiabank on February 4, 2025. The analyst firm set a price target for $62.00 expecting TWST to rise to within 12 months (a possible 37.96% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Twist Bioscience (TWST)?
The latest analyst rating for Twist Bioscience (NASDAQ:TWST) was provided by Scotiabank, and Twist Bioscience maintained their sector outperform rating.
When was the last upgrade for Twist Bioscience (TWST)?
The last upgrade for Twist Bioscience Corp happened on January 17, 2024 when Goldman Sachs raised their price target to $45. Goldman Sachs previously had a neutral for Twist Bioscience Corp.
When was the last downgrade for Twist Bioscience (TWST)?
There is no last downgrade for Twist Bioscience.
When is the next analyst rating going to be posted or updated for Twist Bioscience (TWST)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Twist Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Twist Bioscience was filed on February 4, 2025 so you should expect the next rating to be made available sometime around February 4, 2026.
Is the Analyst Rating Twist Bioscience (TWST) correct?
While ratings are subjective and will change, the latest Twist Bioscience (TWST) rating was a maintained with a price target of $54.00 to $62.00. The current price Twist Bioscience (TWST) is trading at is $44.94, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.